Chabiotech Co.,Ltd. Logo

Chabiotech Co.,Ltd.

Develops cell/gene therapies and provides CDMO and bio-banking services.

085660 | KO

Overview

Corporate Details

ISIN(s):
KR7085660009
LEI:
Country:
South Korea
Address:
서울특별시 강남구 도산대로 442 청담동 피엔폴루스 3층, 강남구

Description

Chabiotech Co., Ltd. is a biotechnology company specializing in the research and development of cell and gene therapies for rare cancers and incurable diseases. The company's core activities include advancing its therapeutic pipelines and providing global Contract Development and Manufacturing Organization (CDMO) services for advanced biopharmaceuticals, including full-scale GMP production and testing. Chabiotech also operates bio-banking services, such as cord blood and immune/stem cell storage, utilizing advanced cryopreservation technology. Its diversified business segments extend to genomics for precision medicine, healthcare IT solutions that integrate AI and Big Data, comprehensive wellness programs, and specialized healthcare consulting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-12-14 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2021-11-12 00:00
분기보고서 (2021.09)
Korean 3.1 MB
2021-11-11 00:00
주식등의대량보유상황보고서(일반)
Korean 162.1 KB
2021-11-11 00:00
투자판단관련주요경영사항(고형암 환자를 대상으로 하는 'CBT101' 임상 1상 임상시험 종료 보고)
Korean 12.4 KB
2021-11-08 00:00
기타경영사항(특허권취득)(자율공시)(다능성 줄기세포 유래 중간엽 줄기세포 직접 분화용 배지, 그를 이용하여 중간엽 줄기세포를 제조하는 방법, …
Korean 5.7 KB
2021-10-28 00:00
주식등의대량보유상황보고서(일반)
Korean 166.8 KB
2021-10-19 00:00
기업설명회(IR)개최
Korean 7.7 KB
2021-10-18 00:00
기업설명회(IR)개최
Korean 7.4 KB
2021-10-05 00:00
주식등의대량보유상황보고서(일반)
Korean 166.4 KB
2021-08-17 00:00
주식등의대량보유상황보고서(일반)
Korean 166.4 KB
2021-08-13 00:00
반기보고서 (2021.06)
Korean 3.0 MB
2021-08-13 00:00
[기재정정]반기보고서 (2021.06)
Korean 3.0 MB
2021-07-23 00:00
주식등의대량보유상황보고서(일반)
Korean 201.1 KB
2021-07-23 00:00
전환청구권행사(제6회차)
Korean 12.9 KB
2021-07-23 00:00
신주인수권행사(제7회차)
Korean 12.4 KB

Automate Your Workflow. Get a real-time feed of all Chabiotech Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chabiotech Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chabiotech Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.